The Long Pentraxin PTX3 Is Crucial for Tissue Inflammation after Intestinal Ischemia and Reperfusion in Mice
- 30 April 2009
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 174 (4), 1309-1318
- https://doi.org/10.2353/ajpath.2009.080240
Abstract
No abstract availableFunding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fondazione Cariplo
- National Institutes of Health (HD33438)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Sixth Framework Programme (LSHB-CT-2005-005203, LSHB-CT-2005-518167)
This publication has 44 references indexed in Scilit:
- Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial InfarctionCirculation, 2008
- Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina PectorisArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Plasminogen/plasmin regulates α-enolase expression through the MEK/ERK pathwayBiochemical and Biophysical Research Communications, 2005
- Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusionKidney International, 2005
- Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injuryBritish Journal of Pharmacology, 2004
- Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of ApoptosisPublished by Elsevier BV ,2004
- Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseNature, 2002
- Effects of inhibition of PDE4 and TNF‐α on local and remote injuries following ischaemia and reperfusion injuryBritish Journal of Pharmacology, 2001
- Role of tumour necrosis factor in lung injury caused by intestinal ischaemia–reperfusionBritish Journal of Surgery, 2001
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998